APLICACIÓN CÉLULAS MADRE

As we know, circulating progenitor cells are believed to participate in cardiovascular (CV) homeostasis, and CV damage is link to decrease CD34 and CD133, several trials show, stem cell contribute to endothelial homeostasis and repair, still metabolic syndrome is associates with increased endothelial dysfunction and a high risk of cardiovascular events and death, rising circulate stem cell, modulates outcomes in the metabolic syndrome, and loss circulating stem cell, increase cardiovascular disease development and progression over the long-term.